With EGFP-EGF1 fusion protein, which has a specific affinity to tissue factor protein, ENPs could be effectively absorbed by injured BMECs, neuroglial cells and glioma cells and work as a carrier for targeting drug delivery. Here, GFM1 is linked to central nervous system cancer.